Serostim® [clinicaltrials_resource:3ac37aef162f2f88a8a53afa1f48e103]
intervention [clinicaltrials_vocabulary:intervention]
Serostim® [clinicaltrials_resource:3ac37aef162f2f88a8a53afa1f48e103]
Bio2RDF identifier
3ac37aef162f2f88a8a53afa1f48e103
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:3ac37aef162f2f88a8a53afa1f48e103
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
Serostim® will be administered ...... ly dose of 4 mg up to Week 24.
intervention name [clinicaltrials_vocabulary:intervention-name]
other name [clinicaltrials_vocabulary:other-name]
Recombinant human growth hormone (r-hGH)
identifier
clinicaltrials_resource:3ac37aef162f2f88a8a53afa1f48e103
title
Serostim®
@en
type
label
Serostim® [clinicaltrials_resource:3ac37aef162f2f88a8a53afa1f48e103]
@en